Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
42
AKZOY Quote, Financials, Valuation and Earnings
Last price:
$23.31
Seasonality move
:
2.15%
Day range:
$23.05 - $23.15
52-week range:
$18.07 - $24.52
Dividend yield:
3.26%
P/E ratio:
253.01x
P/S ratio:
1.04x
P/B ratio:
2.57x
Volume:
31.9K
Avg. volume:
97.9K
1-year change:
16.04%
Market cap:
$11.9B
Revenue:
$11.6B
EPS (TTM):
$0.09
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AKZOY
Akzo Nobel NV
|
$2.9B | -- | 5.48% | -- | $27.15 |
|
AMVMF
AMG Critical Materials NV
|
-- | -- | -- | -- | -- |
|
AVTXF
Avantium NV
|
-- | -- | -- | -- | -- |
|
CSNVY
Corbion NV
|
-- | -- | -- | -- | -- |
|
IMCDY
IMCD NV
|
-- | -- | -- | -- | -- |
|
OCINF
OCI NV
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AKZOY
Akzo Nobel NV
|
$23.15 | $27.15 | $11.9B | 253.01x | $0.17 | 3.26% | 1.04x |
|
AMVMF
AMG Critical Materials NV
|
$33.00 | -- | $1.1B | 29.85x | $0.23 | 1.38% | 0.68x |
|
AVTXF
Avantium NV
|
$15.10 | -- | $65.3M | -- | $0.00 | 0% | 7.35x |
|
CSNVY
Corbion NV
|
$21.20 | -- | $1.2B | 16.71x | $0.72 | 3.41% | 0.88x |
|
IMCDY
IMCD NV
|
$45.25 | -- | $5.3B | 18.19x | $1.22 | 5.37% | 1.01x |
|
OCINF
OCI NV
|
$3.51 | -- | $740.4M | 0.38x | $3.31 | 0% | 0.29x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AKZOY
Akzo Nobel NV
|
57.65% | 0.042 | 50.37% | 0.82x |
|
AMVMF
AMG Critical Materials NV
|
58.43% | 2.156 | 71.92% | 0.63x |
|
AVTXF
Avantium NV
|
-- | -1.129 | -- | -- |
|
CSNVY
Corbion NV
|
36.82% | 1.472 | -- | 0.58x |
|
IMCDY
IMCD NV
|
41.75% | 0.634 | -- | 1.27x |
|
OCINF
OCI NV
|
71.1% | 0.816 | 37.69% | 0.09x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AKZOY
Akzo Nobel NV
|
$1.2B | $331.9M | 0.84% | 1.89% | 11.15% | $310.2M |
|
AMVMF
AMG Critical Materials NV
|
$90M | $34.9M | 3.07% | 7.45% | 8.04% | -$28.6M |
|
AVTXF
Avantium NV
|
-- | -- | -- | -- | -- | -- |
|
CSNVY
Corbion NV
|
-- | $35.8M | 15.28% | 26.74% | 10.31% | -- |
|
IMCDY
IMCD NV
|
-- | -- | 8.71% | 14.69% | -- | -- |
|
OCINF
OCI NV
|
$58.7M | -$28.4M | -4.37% | -10.39% | -11.68% | $65.1M |
Akzo Nobel NV vs. Competitors
-
Which has Higher Returns AKZOY or AMVMF?
AMG Critical Materials NV has a net margin of -7.46% compared to Akzo Nobel NV's net margin of 3.16%. Akzo Nobel NV's return on equity of 1.89% beat AMG Critical Materials NV's return on equity of 7.45%.
Company Gross Margin Earnings Per Share Invested Capital AKZOYAkzo Nobel NV40.32% -$0.44 $11.2B AMVMFAMG Critical Materials NV20.7% $0.39 $1.4B -
What do Analysts Say About AKZOY or AMVMF?
Akzo Nobel NV has a consensus price target of $27.15, signalling upside risk potential of 17.28%. On the other hand AMG Critical Materials NV has an analysts' consensus of -- which suggests that it could fall by --. Given that Akzo Nobel NV has higher upside potential than AMG Critical Materials NV, analysts believe Akzo Nobel NV is more attractive than AMG Critical Materials NV.
Company Buy Ratings Hold Ratings Sell Ratings AKZOYAkzo Nobel NV1 0 0 AMVMFAMG Critical Materials NV0 0 0 -
Is AKZOY or AMVMF More Risky?
Akzo Nobel NV has a beta of 1.086, which suggesting that the stock is 8.637% more volatile than S&P 500. In comparison AMG Critical Materials NV has a beta of 1.198, suggesting its more volatile than the S&P 500 by 19.814%.
-
Which is a Better Dividend Stock AKZOY or AMVMF?
Akzo Nobel NV has a quarterly dividend of $0.17 per share corresponding to a yield of 3.26%. AMG Critical Materials NV offers a yield of 1.38% to investors and pays a quarterly dividend of $0.23 per share. Akzo Nobel NV pays 51.59% of its earnings as a dividend. AMG Critical Materials NV pays out 58.45% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AKZOY or AMVMF?
Akzo Nobel NV quarterly revenues are $3B, which are larger than AMG Critical Materials NV quarterly revenues of $434.7M. Akzo Nobel NV's net income of -$222M is lower than AMG Critical Materials NV's net income of $13.7M. Notably, Akzo Nobel NV's price-to-earnings ratio is 253.01x while AMG Critical Materials NV's PE ratio is 29.85x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Akzo Nobel NV is 1.04x versus 0.68x for AMG Critical Materials NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AKZOYAkzo Nobel NV1.04x 253.01x $3B -$222M AMVMFAMG Critical Materials NV0.68x 29.85x $434.7M $13.7M
-
Which has Higher Returns AKZOY or AVTXF?
Avantium NV has a net margin of -7.46% compared to Akzo Nobel NV's net margin of --. Akzo Nobel NV's return on equity of 1.89% beat Avantium NV's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital AKZOYAkzo Nobel NV40.32% -$0.44 $11.2B AVTXFAvantium NV-- -- -- -
What do Analysts Say About AKZOY or AVTXF?
Akzo Nobel NV has a consensus price target of $27.15, signalling upside risk potential of 17.28%. On the other hand Avantium NV has an analysts' consensus of -- which suggests that it could fall by --. Given that Akzo Nobel NV has higher upside potential than Avantium NV, analysts believe Akzo Nobel NV is more attractive than Avantium NV.
Company Buy Ratings Hold Ratings Sell Ratings AKZOYAkzo Nobel NV1 0 0 AVTXFAvantium NV0 0 0 -
Is AKZOY or AVTXF More Risky?
Akzo Nobel NV has a beta of 1.086, which suggesting that the stock is 8.637% more volatile than S&P 500. In comparison Avantium NV has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock AKZOY or AVTXF?
Akzo Nobel NV has a quarterly dividend of $0.17 per share corresponding to a yield of 3.26%. Avantium NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Akzo Nobel NV pays 51.59% of its earnings as a dividend. Avantium NV pays out -- of its earnings as a dividend. Akzo Nobel NV's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AKZOY or AVTXF?
Akzo Nobel NV quarterly revenues are $3B, which are larger than Avantium NV quarterly revenues of --. Akzo Nobel NV's net income of -$222M is higher than Avantium NV's net income of --. Notably, Akzo Nobel NV's price-to-earnings ratio is 253.01x while Avantium NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Akzo Nobel NV is 1.04x versus 7.35x for Avantium NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AKZOYAkzo Nobel NV1.04x 253.01x $3B -$222M AVTXFAvantium NV7.35x -- -- --
-
Which has Higher Returns AKZOY or CSNVY?
Corbion NV has a net margin of -7.46% compared to Akzo Nobel NV's net margin of --. Akzo Nobel NV's return on equity of 1.89% beat Corbion NV's return on equity of 26.74%.
Company Gross Margin Earnings Per Share Invested Capital AKZOYAkzo Nobel NV40.32% -$0.44 $11.2B CSNVYCorbion NV-- -- $1.3B -
What do Analysts Say About AKZOY or CSNVY?
Akzo Nobel NV has a consensus price target of $27.15, signalling upside risk potential of 17.28%. On the other hand Corbion NV has an analysts' consensus of -- which suggests that it could fall by --. Given that Akzo Nobel NV has higher upside potential than Corbion NV, analysts believe Akzo Nobel NV is more attractive than Corbion NV.
Company Buy Ratings Hold Ratings Sell Ratings AKZOYAkzo Nobel NV1 0 0 CSNVYCorbion NV0 0 0 -
Is AKZOY or CSNVY More Risky?
Akzo Nobel NV has a beta of 1.086, which suggesting that the stock is 8.637% more volatile than S&P 500. In comparison Corbion NV has a beta of 0.472, suggesting its less volatile than the S&P 500 by 52.81%.
-
Which is a Better Dividend Stock AKZOY or CSNVY?
Akzo Nobel NV has a quarterly dividend of $0.17 per share corresponding to a yield of 3.26%. Corbion NV offers a yield of 3.41% to investors and pays a quarterly dividend of $0.72 per share. Akzo Nobel NV pays 51.59% of its earnings as a dividend. Corbion NV pays out 54.35% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AKZOY or CSNVY?
Akzo Nobel NV quarterly revenues are $3B, which are larger than Corbion NV quarterly revenues of $346.9M. Akzo Nobel NV's net income of -$222M is higher than Corbion NV's net income of --. Notably, Akzo Nobel NV's price-to-earnings ratio is 253.01x while Corbion NV's PE ratio is 16.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Akzo Nobel NV is 1.04x versus 0.88x for Corbion NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AKZOYAkzo Nobel NV1.04x 253.01x $3B -$222M CSNVYCorbion NV0.88x 16.71x $346.9M --
-
Which has Higher Returns AKZOY or IMCDY?
IMCD NV has a net margin of -7.46% compared to Akzo Nobel NV's net margin of 5.48%. Akzo Nobel NV's return on equity of 1.89% beat IMCD NV's return on equity of 14.69%.
Company Gross Margin Earnings Per Share Invested Capital AKZOYAkzo Nobel NV40.32% -$0.44 $11.2B IMCDYIMCD NV-- $0.61 $4B -
What do Analysts Say About AKZOY or IMCDY?
Akzo Nobel NV has a consensus price target of $27.15, signalling upside risk potential of 17.28%. On the other hand IMCD NV has an analysts' consensus of -- which suggests that it could fall by --. Given that Akzo Nobel NV has higher upside potential than IMCD NV, analysts believe Akzo Nobel NV is more attractive than IMCD NV.
Company Buy Ratings Hold Ratings Sell Ratings AKZOYAkzo Nobel NV1 0 0 IMCDYIMCD NV0 0 0 -
Is AKZOY or IMCDY More Risky?
Akzo Nobel NV has a beta of 1.086, which suggesting that the stock is 8.637% more volatile than S&P 500. In comparison IMCD NV has a beta of 1.014, suggesting its more volatile than the S&P 500 by 1.43%.
-
Which is a Better Dividend Stock AKZOY or IMCDY?
Akzo Nobel NV has a quarterly dividend of $0.17 per share corresponding to a yield of 3.26%. IMCD NV offers a yield of 5.37% to investors and pays a quarterly dividend of $1.22 per share. Akzo Nobel NV pays 51.59% of its earnings as a dividend. IMCD NV pays out 36.69% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AKZOY or IMCDY?
Akzo Nobel NV quarterly revenues are $3B, which are larger than IMCD NV quarterly revenues of $1.3B. Akzo Nobel NV's net income of -$222M is lower than IMCD NV's net income of $72.6M. Notably, Akzo Nobel NV's price-to-earnings ratio is 253.01x while IMCD NV's PE ratio is 18.19x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Akzo Nobel NV is 1.04x versus 1.01x for IMCD NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AKZOYAkzo Nobel NV1.04x 253.01x $3B -$222M IMCDYIMCD NV1.01x 18.19x $1.3B $72.6M
-
Which has Higher Returns AKZOY or OCINF?
OCI NV has a net margin of -7.46% compared to Akzo Nobel NV's net margin of -3.19%. Akzo Nobel NV's return on equity of 1.89% beat OCI NV's return on equity of -10.39%.
Company Gross Margin Earnings Per Share Invested Capital AKZOYAkzo Nobel NV40.32% -$0.44 $11.2B OCINFOCI NV11.86% -$0.08 $4.1B -
What do Analysts Say About AKZOY or OCINF?
Akzo Nobel NV has a consensus price target of $27.15, signalling upside risk potential of 17.28%. On the other hand OCI NV has an analysts' consensus of -- which suggests that it could fall by --. Given that Akzo Nobel NV has higher upside potential than OCI NV, analysts believe Akzo Nobel NV is more attractive than OCI NV.
Company Buy Ratings Hold Ratings Sell Ratings AKZOYAkzo Nobel NV1 0 0 OCINFOCI NV0 0 0 -
Is AKZOY or OCINF More Risky?
Akzo Nobel NV has a beta of 1.086, which suggesting that the stock is 8.637% more volatile than S&P 500. In comparison OCI NV has a beta of 0.071, suggesting its less volatile than the S&P 500 by 92.856%.
-
Which is a Better Dividend Stock AKZOY or OCINF?
Akzo Nobel NV has a quarterly dividend of $0.17 per share corresponding to a yield of 3.26%. OCI NV offers a yield of 0% to investors and pays a quarterly dividend of $3.31 per share. Akzo Nobel NV pays 51.59% of its earnings as a dividend. OCI NV pays out -- of its earnings as a dividend. Akzo Nobel NV's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios AKZOY or OCINF?
Akzo Nobel NV quarterly revenues are $3B, which are larger than OCI NV quarterly revenues of $494.9M. Akzo Nobel NV's net income of -$222M is lower than OCI NV's net income of -$15.8M. Notably, Akzo Nobel NV's price-to-earnings ratio is 253.01x while OCI NV's PE ratio is 0.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Akzo Nobel NV is 1.04x versus 0.29x for OCI NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AKZOYAkzo Nobel NV1.04x 253.01x $3B -$222M OCINFOCI NV0.29x 0.38x $494.9M -$15.8M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 6.15% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 3.93% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 9.59% over the past day.
